Improved median overall survival (OS) in patients with metastatic melanoma (mM) treated with high-dose (HD) IL-2: Analysis of the PROCLAIM 2007-2012 national registry.
Gregory A. Daniels
Consultant or Advisory Role - Prometheus
Michael Morse
Consultant or Advisory Role - Prometheus
Michael K.K. Wong
Consultant or Advisory Role - Prometheus
Howard Kaufman
Consultant or Advisory Role - Prometheus
David F. McDermott
Consultant or Advisory Role - Prometheus
Sandra Aung
Employment or Leadership Position - Prometheus
James N. Lowder
Employment or Leadership Position - Prometheus